Grifols S.A. Logo

Grifols S.A.

Leading producer of plasma-derived medicines for patients with rare and chronic diseases.

GRF | MC

Overview

Corporate Details

ISIN(s):
ES0171996087 (+4 more)
LEI:
959800HSSNXWRKBK4N60
Country:
Spain
Address:
Avenida de la Generalitat 152-158, 08174 Sant Cugat del Vallès
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Grifols is a global healthcare company and a leading producer of plasma-derived medicines. Founded in 1909, the company develops, produces, and markets innovative biopharmaceuticals and solutions in transfusion medicine to improve the health and well-being of people worldwide. Its core activities are centered on its expertise in plasma science, serving patients with chronic and rare diseases across various therapeutic areas, including immunology, neurology, and critical care. Grifols provides a range of products and services through its primary divisions: Bioscience, Diagnostic, and Hospital. The company is committed to the highest standards of safety and quality, leveraging scientific innovation to treat diseases and enhance patient lives.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-06-13 00:00
Director's Dealing
Motivo de la notificación: Persona Estrechamente Vinculada
Spanish 91.4 KB
2025-06-06 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-19 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-16 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-12 17:36
Earnings Release
Grifols anuncia la información financiera del primer trimestre de 2025
Spanish 1.3 MB
2025-05-06 12:54
M&A Activity
Como continuación de la Información Privilegiada presentada por Grifols el 31 d…
Spanish 43.3 KB
2025-05-02 08:04
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas 2025 de Grifols, S.A.
Spanish 137.8 KB
2025-05-02 00:00
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas 2025 de Grifols, S.A.
Spanish 137.8 KB
2025-04-02 13:40
M&A Activity
Brookfield Capital Partners realiza comunicación en relación a noticias de pren…
Spanish 86.2 KB
2025-04-02 11:30
Regulatory News Service
Con respecto a la información publicada en ciertos medios de comunicación.
Spanish 39.1 KB
2025-03-31 08:57
Delisting Announcement
El Consejo de Administración ha aprobado por unanimidad que su filial Grifols B…
Spanish 41.6 KB
2025-03-14 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-03-10 12:55
Legal Proceedings Report
Grifols desea informar sobre cierta información publicada en un medio de comuni…
Spanish 54.6 KB
2025-03-05 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 94.7 KB

Automate Your Workflow. Get a real-time feed of all Grifols S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Grifols S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
ADBIOTECH Co.,Ltd. Logo
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
South Korea 179530
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Develops user-friendly, saliva-based tests for health monitoring & therapeutic drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics, managing the full value chain from R&D to sales.
Japan 2927
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK
Alkaloid AD Logo
Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.
North Macedonia ALK
ALLERGY THERAPEUTICS PLC Logo
Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.
United Kingdom AGY
Alligator Bioscience Logo
Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.
Sweden ATORX

Talk to a Data Expert

Have a question? We'll get back to you promptly.